LENZ
Price
$29.21
Change
-$3.20 (-9.87%)
Updated
Dec 18, 04:59 PM (EDT)
MBCOF
Price
$0.11
Change
+$0.01 (+10.00%)
Updated
Dec 16 closing price
Ad is loading...

LENZ vs MBCOF

Header iconLENZ vs MBCOF Comparison
Open Charts LENZ vs MBCOFBanner chart's image
LENZ Therapeutics
Price$29.21
Change-$3.20 (-9.87%)
Volume$14.53K
CapitalizationN/A
MARVEL BIOSCIENCES
Price$0.11
Change+$0.01 (+10.00%)
Volume$11.5K
CapitalizationN/A
LENZ vs MBCOF Comparison Chart
Loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LENZ vs. MBCOF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and MBCOF is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (LENZ: $32.41 vs. MBCOF: $0.11)
Brand notoriety: LENZ and MBCOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 116% vs. MBCOF: 100%
Market capitalization -- LENZ: $891.3M vs. MBCOF: $4.56M
LENZ [@Biotechnology] is valued at $891.3M. MBCOF’s [@Biotechnology] market capitalization is $4.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 0 FA rating(s) are green whileMBCOF’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 0 green, 5 red.
  • MBCOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both LENZ and MBCOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish.

  • LENZ’s TA Score: 4 bullish, 5 bearish.

Price Growth

LENZ (@Biotechnology) experienced а -4.56% price change this week, while MBCOF (@Biotechnology) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

LENZ is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($891M) has a higher market cap than MBCOF($4.56M). LENZ YTD gains are higher at: 1137.023 vs. MBCOF (51.983).
LENZMBCOFLENZ / MBCOF
Capitalization891M4.56M19,531%
EBITDAN/AN/A-
Gain YTD1137.02351.9832,187%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
LENZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and IVEVF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
N/A
IVEVF - MBCOF
32%
Poorly correlated
N/A
SLDB - MBCOF
25%
Poorly correlated
-3.04%
LENZ - MBCOF
20%
Poorly correlated
+5.06%
BSFAF - MBCOF
7%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-7.92%
More